Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis

The novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus) has emerged as a significant threat to public health with startling drawbacks in all sectors globally. This study investigates the practicality of some medicinal plants for SARS-CoV-2 therapy using a systematic review and meta-anal...

Full description

Saved in:
Bibliographic Details
Main Authors: EBENEZER OLUWAKEMI, BODEDE OLUSOLA, AWOLADE PAUL, JORDAAN MARYAM A., OGUNSAKIN ROPO E., SHAPI MICHAEL
Format: Article
Language:English
Published: Sciendo 2022-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2022-0021
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574006809591808
author EBENEZER OLUWAKEMI
BODEDE OLUSOLA
AWOLADE PAUL
JORDAAN MARYAM A.
OGUNSAKIN ROPO E.
SHAPI MICHAEL
author_facet EBENEZER OLUWAKEMI
BODEDE OLUSOLA
AWOLADE PAUL
JORDAAN MARYAM A.
OGUNSAKIN ROPO E.
SHAPI MICHAEL
author_sort EBENEZER OLUWAKEMI
collection DOAJ
description The novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus) has emerged as a significant threat to public health with startling drawbacks in all sectors globally. This study investigates the practicality of some medicinal plants for SARS-CoV-2 therapy using a systematic review and meta-analysis of their reported SARS-CoV-1 inhibitory potencies. Relevant data were systematically gathered from three databases, viz., Web of Science, PubMed and Scopus. The information obtained included botanical information, extraction method and extracts concentrations, as well as the proposed mechanisms. Fourteen articles describing 30 different plants met our eligibility criteria. Random effects model and subgroup analysis were applied to investigate heterogeneity. According to subgroup analysis, the substantial heterogeneity of the estimated mean based on the IC50 values reporting the most potent anti-SARS-CoV 3C--like protease (3CLpro) inhibitors (10.07 %, p < 0.0001), was significantly higher compared to the most active anti-SARS-CoV papain-like protease (PLpro) inhibitors (6.12 %, p < 0.0001). More importantly, the literature analysis revealed that fruit extracts of Rheum palmatum L. and the compound cryptotanshinone isolated from the root of Salvia miltiorrhiza (IC50 = 0.8 ± 0.2 μmol L–1) were excellent candidates for anti--SARS-CoV targeting PLpro. Meanwhile, iguesterin (IC50 = 2.6 ± 0.6 μmol L–1) isolated from the bark of Tripterygium regelii emerged as the most excellent candidate for anti-SARS--CoV targeting 3CLpro. The present systematic review and meta-analysis provide valuable and comprehensive information about potential medicinal plants for SARS-CoV-2 inhibition. The chemotypes identified herein can be adopted as a starting point for developing new drugs to contain the novel virus.
format Article
id doaj-art-e9bc270ccf414c2d9b0ceaf884d559ed
institution Kabale University
issn 1846-9558
language English
publishDate 2022-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-e9bc270ccf414c2d9b0ceaf884d559ed2025-02-02T01:41:29ZengSciendoActa Pharmaceutica1846-95582022-06-0172219922410.2478/acph-2022-0021Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysisEBENEZER OLUWAKEMI0BODEDE OLUSOLA1AWOLADE PAUL2JORDAAN MARYAM A.3OGUNSAKIN ROPO E.4SHAPI MICHAEL51Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu HighwayDurban, 4000, South Africa2Department of Agriculture and Animal Health, University of South Africa Florida Campus, Florida, 1710South Africa3School of Chemistry and Physics University of KwaZulu-Natal P/Bag X54001, Westville, DurbanSouth Africa1Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu HighwayDurban, 4000, South Africa4Discipline of Public Health Medicine College of Health Sciences University of KwaZulu Natal, Durban4001, South Africa1Faculty of Natural Science, Department of Chemistry, Mangosuthu University of Technology, 511 Mangosuthu HighwayDurban, 4000, South AfricaThe novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus) has emerged as a significant threat to public health with startling drawbacks in all sectors globally. This study investigates the practicality of some medicinal plants for SARS-CoV-2 therapy using a systematic review and meta-analysis of their reported SARS-CoV-1 inhibitory potencies. Relevant data were systematically gathered from three databases, viz., Web of Science, PubMed and Scopus. The information obtained included botanical information, extraction method and extracts concentrations, as well as the proposed mechanisms. Fourteen articles describing 30 different plants met our eligibility criteria. Random effects model and subgroup analysis were applied to investigate heterogeneity. According to subgroup analysis, the substantial heterogeneity of the estimated mean based on the IC50 values reporting the most potent anti-SARS-CoV 3C--like protease (3CLpro) inhibitors (10.07 %, p < 0.0001), was significantly higher compared to the most active anti-SARS-CoV papain-like protease (PLpro) inhibitors (6.12 %, p < 0.0001). More importantly, the literature analysis revealed that fruit extracts of Rheum palmatum L. and the compound cryptotanshinone isolated from the root of Salvia miltiorrhiza (IC50 = 0.8 ± 0.2 μmol L–1) were excellent candidates for anti--SARS-CoV targeting PLpro. Meanwhile, iguesterin (IC50 = 2.6 ± 0.6 μmol L–1) isolated from the bark of Tripterygium regelii emerged as the most excellent candidate for anti-SARS--CoV targeting 3CLpro. The present systematic review and meta-analysis provide valuable and comprehensive information about potential medicinal plants for SARS-CoV-2 inhibition. The chemotypes identified herein can be adopted as a starting point for developing new drugs to contain the novel virus.https://doi.org/10.2478/acph-2022-0021covid-19 main proteaseinhibitionmedicinal plantssystematic reviewmeta-analysis
spellingShingle EBENEZER OLUWAKEMI
BODEDE OLUSOLA
AWOLADE PAUL
JORDAAN MARYAM A.
OGUNSAKIN ROPO E.
SHAPI MICHAEL
Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
Acta Pharmaceutica
covid-19 main protease
inhibition
medicinal plants
systematic review
meta-analysis
title Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
title_full Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
title_fullStr Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
title_full_unstemmed Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
title_short Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
title_sort medicinal plants with anti sars cov activity repurposing for treatment of covid 19 infection a systematic review and meta analysis
topic covid-19 main protease
inhibition
medicinal plants
systematic review
meta-analysis
url https://doi.org/10.2478/acph-2022-0021
work_keys_str_mv AT ebenezeroluwakemi medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis
AT bodedeolusola medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis
AT awoladepaul medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis
AT jordaanmaryama medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis
AT ogunsakinropoe medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis
AT shapimichael medicinalplantswithantisarscovactivityrepurposingfortreatmentofcovid19infectionasystematicreviewandmetaanalysis